Navigation Links
Amylin and Lilly Seek Expanded Use of BYETTA® Along with Basal Insulin
Date:12/22/2010

re kidney problems, and should be used with caution in people who have had a kidney transplant. Patients should talk with their healthcare provider if they have severe problems with their stomach, such as delayed emptying of the stomach (gastroparesis) or problems with digesting food. Severe allergic reactions can happen with BYETTA.

The most common side effects with BYETTA include nausea, vomiting, diarrhea, dizziness, headache, feeling jittery, and acid stomach. Nausea most commonly happens when first starting BYETTA, but may become less over time.

These are not all the side effects from use of BYETTA. A healthcare provider should be consulted about any side effect that is bothersome or does not go away.

For additional important safety information about BYETTA, please see the full Prescribing Information (www.byetta.com/pi) and Medication Guide (www.byetta.com/mg).

About Amylin and Lilly

Amylin Pharmaceuticals is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and BYETTA® (exenatide) injection. Amylin's research and development activities leverage the Company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is headquartered in San Diego. Further information on Amylin Pharmaceuticals is available at www.amylin.com.

Through a long-standing commitment to diabetes care, Lilly seeks to provide patients with breakthrough treatments that enable them to live longer, healthier and fuller lives. Since 1923, Lilly has been an industry leader in pioneering therapie
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.; Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Amylin Pharmaceuticals to Present at the Citi 7th Annual US Small/Mid Cap Conference
2. Amylin Pharmaceuticals Announces Third Quarter Product Revenues; Quarterly Update Conference Call Canceled
3. Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare and Baird Global Healthcare Conferences
4. Amylin Pharmaceuticals to Present at the 2010 Jefferies Global Life Sciences Conference
5. Amylin Pharmaceuticals to Present at the 2010 Citi Investment Research Global Healthcare Conference
6. Amylin Pharmaceuticals to Present at the Deutsche Bank 35th Annual Healthcare Conference
7. Amylin Pharmaceuticals to Webcast Third Quarter Results
8. Amylin and Lilly to Present More than 20 Studies for Exenatide at EASD 2009
9. Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference
10. Amylin Pharmaceuticals Board of Directors Elects Paulo F. Costa Chairman of the Board
11. Amylin Pharmaceuticals to Webcast Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)...  Northwest Biotherapeutics, Inc. (NASDAQ: NWBO ) ("NW ... for cancer, announced today that Dr. Marnix L. ... be making an Industry Expert Theater Presentation at the ... on Saturday, May 30, 2015, from 3 to ... McCormick Place. Dr. Bosch will provide an ...
(Date:5/27/2015)... , May 27, 2015  RXi Pharmaceuticals Corporation ... on discovering and developing innovative therapies primarily in ... update on the status of the Company,s Series ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ... and 21 shares of Series A Preferred Stock ...
(Date:5/26/2015)... Regenestem Network has announced the grand ... Aires, Argentina. The clinic will be lead by Silvina ... assembled a multidisciplinary team of medical professionals who specialize ... Madero office. , The new Regenestem Network members ... studies in cellular therapies, and establish Regenestem protocols to ...
(Date:5/26/2015)... CITY, California and HILDEN, ... QIAGEN N.V. (NASDAQ: QGEN ; ... launch of its QIAGEN Clinical Insight ® ... testing labs to interpret and report on genomic ... two supported applications for the bioinformatics platform are ...
Breaking Biology Technology:NW Bio To Present Overview Of DCVax-Direct Phase I Trial In Chicago This Weekend 2NW Bio To Present Overview Of DCVax-Direct Phase I Trial In Chicago This Weekend 3RXi Pharmaceuticals Provides an Update on Series A and Series A-1 Preferred Stock 2RXi Pharmaceuticals Provides an Update on Series A and Series A-1 Preferred Stock 3Regenestem Network and Silvina Pastrana, M.D. Announce the Opening of a New Stem Cell Clinic in Buenos Aires 2Regenestem Network and Silvina Pastrana, M.D. Announce the Opening of a New Stem Cell Clinic in Buenos Aires 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 2QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 4QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 5
... June 19 /Xinhua-PRNewswire/ --,Shenzhen Beike Biotechnology Co., Ltd. ... providing safe and effective stem cell applications for,medical ... medical stem cell storage and processing facility in ... Storage Facility will be,one of the most highly ...
... Canopus,BioPharma, Inc. (OTC: CBIA), has confirmed the efficacy ... agent and has also demonstrated the,synergistic effect of ... (Erbitux) in two mice lung cancer models., ... "We at,Canopus are encouraged with the discovery of ...
... 19 Iomai,Corporation (Nasdaq: IOMI ) announced ... Alexander Von Gabain, Ph. D., the Chief Scientific,Officer ... at the Biotechnology,Industry Organization,s International Convention at a ... session will begin at 4 p.m. in room ...
Cached Biology Technology:Beike Biotech Opens Comprehensive Stem Cell Storage and Processing Facility in China 2Beike Biotech Opens Comprehensive Stem Cell Storage and Processing Facility in China 3Beike Biotech Opens Comprehensive Stem Cell Storage and Processing Facility in China 4CB1400, Patented by Canopus BioPharma, Prevents Tumor Growth and Enhances the Anti-Tumor Effects of Cisplatin and Cetuximab (Erbitux). 2Iomai, Intercell Chief Scientific Officers to Speak on Future of Vaccines at BIO International Convention Today 2
(Date:5/22/2015)... Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") announces ... pricing and making the Wocket generally available for $229 via ... of Marketing said, "We,ve extended the opportunity to take advantage ... To get your wocket at this special price, submit your ... June 1, you,ll receive a unique code that gives you ...
(Date:5/20/2015)... May 20, 2015 ... has announced the addition of the  ... Iris Recognition Market"  report to their ... research service analyses trends in the ... and commercial sectors, globally. Despite hardware ...
(Date:5/19/2015)... , May 19, 2015 ... has announced the addition of the  "Genetic ... offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent ... an in-depth analysis of the current and ... of gene-based tests, their working principles and ...
Breaking Biology News(10 mins):NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Global Genetic Testing Market Outlook 2018 2
... the latest twist on optical knots, New York University ... extended and knotted optical traps in three dimensions. This ... Society,s (OSA) open-access journal Optics Express , produces ... traces out a knotted trajectory in space, for the ...
... identifying the cause and level of our responses to any ... argues that human beings are more reliant for their behavioural ... that the accuracy of that information is therefore of unparalleled ... of error and deception, which can seriously affect their chances ...
... University of Miami Rosenstiel School of Marine and Atmospheric Science ... 2011 recipient of The Rosenstiel Award, one of the School,s ... Australia,s University of Queensland, is the 37th recipient of the ... limitations of conservation strategies for coral reefs. Mumby began ...
Cached Biology News:Tying the knot with computer-generated holograms: Winding optical path moves matter 2Tying the knot with computer-generated holograms: Winding optical path moves matter 3Peter Mumby to receive prestigious 2011 Rosenstiel Award from the University of Miami 2
Detect and measure levels of mouse IgG2b antibody isotypes quickly and easily....
... Versatile state of the Art ... flask to dual 38,000 L fermentation. ... scale to production. Aseptic operation ... Batch, Fed-Batch, and Continuous Modes. ...
Request Info...
Immunogen: VDAC3 Protein Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: